Related Experiment Videos
Minocycline-associated lupus erythematosus
P M Gordon1, M I White, R Herriot
1Department of Dermatology, Aberdeen Royal Hospitals NHS Trust, Aberdeen Royal Infirmary, Foresterhill, U.K.
The British Journal of Dermatology
|January 1, 1995
Summary
Minocycline therapy for acne vulgaris may trigger lupus erythematosus symptoms. This is the second reported case linking minocycline use to drug-induced lupus.
Area of Science:
- Dermatology
- Rheumatology
- Pharmacology
Background:
- Acne vulgaris is a common skin condition treated with various antibiotics.
- Minocycline, a tetracycline antibiotic, is frequently prescribed for moderate to severe acne.
- Drug-induced lupus erythematosus (DILE) is a recognized adverse effect of certain medications.
Observation:
- A patient receiving minocycline for acne vulgaris presented with clinical manifestations suggestive of lupus erythematosus.
- The patient's symptoms emerged during or shortly after initiating minocycline treatment.
- Other potential causes for lupus-like symptoms were considered and ruled out.
Findings:
- The temporal association and resolution of symptoms upon minocycline discontinuation strongly suggest a causal link.
- This case represents the second documented instance of minocycline-induced lupus erythematosus.
- The specific mechanism by which minocycline may induce lupus-like symptoms is not fully elucidated but may involve immune dysregulation.
Implications:
- Clinicians should maintain a high index of suspicion for drug-induced lupus in patients on minocycline therapy presenting with relevant symptoms.
- Early recognition and cessation of minocycline can lead to prompt symptom resolution and prevent long-term complications.
- This case highlights the importance of pharmacovigilance and reporting of rare adverse drug reactions to enhance patient safety.